Ban on five of Baba Ramdev's products revoked

The ban imposed on five products of Yoga guru Ramdev's Divya Pharmacy by Uttarakhand Ayurveda and Unani Licensing Authority was revoked. The pharmacy is in charge of manufacturing Patanjali products.

The state's Ayurveda authorities asked the production of medicines - Bpgrit, Madhugrit, Thyrogrit, Lipidom tablets, and Eyegrit Gold tablets - to be halted on November 11. These medicines were used to treat diabetes, blood pressure, goitre, glaucoma, and high cholesterol. The authority has now amended the order and allowed the pharmacy to continue the production, reported Mint.

The action was taken after a doctor from Kerala accused Divya Pharmacy of violating the Drugs and Magic Remedies (objectionable advertisement) Act and the Drugs and Cosmetic Act. He filed a complaint in July 2022. He alleged that these medicines are falsely being promoted for the treatment of ailments.

The drug controller said there was an error in the previous order. However, the production can only restart after the authority approves revised formulation sheets. GCN Jangpangi said the company should have received time to explain its stand. Ramdev's close aide Acharya Balkrishna said he is thankful to the state government for rectifying the error.

Divya Pharmacy responded to the ban by saying, "Patanjali Institute is the first in the world to get an acceptance for Ayurveda medicines as research and evidence-based medicine with 30 years of continuous effort and research. The Honourable Prime Minister is also making efforts to establish pride in his heritage by erasing the signs of all kinds of slavery in the country. The ignorant, insensitive, inept Ayurveda licensing officer of Uttarakhand is not only tarnishing the sage tradition of Ayurveda but the injudicious work and errors of an officer have done a grossly condemnable act of questioning the tradition and authentic research of Ayurveda, tarnishing it."